Drug intelligence / Profile preview

macrogol 3350 + sodium chloride + sodium bicarbonate + potassium chloride (Stirling Anglian Pharmaceuticals)

Development stage
Unknown
Lead developer
Stirling Anglian Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

CosmoCol Half is an osmotic laxative marketed by Stirling Anglian Pharmaceuticals for the treatment of chronic constipation and faecal impaction. It is a combination formulation consisting of macrogol 3350 (polyethylene glycol) and a specific blend of electrolytes, including sodium chloride, sodium bicarbonate, and potassium chloride. The mechanism of action involves macrogol 3350 acting as an osmotic agent that binds water in the gastrointestinal tract, thereby increasing stool volume and softening consistency to promote bowel movements. The electrolyte components are included to ensure that there is no net gain or loss of water, sodium, potassium, or bicarbonate from the body during the laxative process. CosmoCol Half provides a lower dose of active ingredients per sachet compared to the standard CosmoCol formulation, allowing for more precise dose titration in various patient populations.

Brand names
CosmoCol HalfCosmoColCosmoCol Paediatric
Other names
PEG 3350 + electrolytespolyethylene glycol 3350 + electrolytes
02

Targets

Bulk water in intestinal lumen

Beyond the preview

Go deeper on macrogol 3350 + sodium chloride + sodium bicarbonate + potassium chloride (Stirling Anglian Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on macrogol 3350 + sodium chloride + sodium bicarbonate + potassium chloride (Stirling Anglian Pharmaceuticals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call